Quick Order Cart

Cat. No. ARG32623

HSPA2 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

HSPA2 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout pool derived from SK-HEP-1 human liver adenocarcinoma epithelial cells, offering a heterogeneous HSPA2 loss-of-function model for hepatocellular carcinoma research. HSPA2, a heat shock-inducible HSP70 chaperone activated by HSF1, maintains proteostasis and promotes survival via stabilization of AKT and ERK client proteins and modulation of BCL2-family apoptosis regulators. Disruption of HSPA2 impairs protein folding capacity and sensitizes cells to stress-induced apoptosis, making this model ideal for studying chaperone-dependent tumor cell resilience, heat shock response, and apoptosis regulation. Applications include drug sensitivity screening, signal transduction analysis, and proteostasis studies using techniques such as western blotting, flow cytometry, and viability assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    HSPA2

    Gene Identifier

    NCBI Gene ID 3306

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

HSPA2 Knockout SK-HEP-1 Polyclonal Cells constitute a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human liver adenocarcinoma epithelial line via targeted HSPA2 gene disruption. As a polyclonal pool, this model provides a heterogeneous loss-of-function system that avoids clonal biases inherent to single-cell clones, enabling robust population-level interrogation of HSPA2 biology.

SK-HEP-1 cells, isolated from a liver adenocarcinoma, serve as a well-established adherent epithelial model for hepatocellular carcinoma research. This cell line retains key oncogenic properties and liver-specific pathways, making it ideal for studying tumor cell proteostasis, drug response, and stress adaptation mechanisms.

HSPA2 encodes a stress-inducible molecular chaperone of the HSP70 family that is transcriptionally upregulated by heat shock factor 1 (HSF1) under heat stress, oxidative stress, and hypoxia (via HIF1A). The protein cooperates with co-chaperones DNAJB1, BAG1, STIP1/HOP, and HSP90 to perform ATP-dependent folding and prevent aggregation of client proteins. Among its clients, HSPA2 stabilizes AKT and ERK kinases, which promote survival and proliferation signaling, and interacts with BCL2 family members to regulate apoptosis. Thus, HSPA2 integrates upstream stress signals with downstream survival and cell death decisions.

In SK-HEP-1 liver cancer cells, HSPA2 disruption compromises proteostasis and diminishes the chaperone??s ability to buffer oncogenic stress, leading to destabilization of AKT/ERK signaling and sensitization to apoptosis. This polyclonal knockout pool is therefore valuable for examining chaperone addiction in hepatocellular carcinoma, testing chemotherapeutic sensitivity, and exploring the mechanistic link between heat shock response and tumor cell survival.

This knockout model supports diverse experimental workflows, including western blotting and RT-qPCR for expression profiling, flow cytometry for apoptosis quantification, MTT-based proliferation assays, and co-immunoprecipitation to probe protein interactions. Heat shock response assays can directly assess stress-induced chaperone activity. Broad applications span cancer biology, protein homeostasis, stress signaling, and drug screening in liver cancer contexts. For additional details, contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)